Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Shkreli's"


9 mentions found


Supreme Court rejects Martin Shkreli fine appeal
  + stars: | 2024-10-07 | by ( Dan Mangan | ) www.cnbc.com   time to read: +3 min
The Supreme Court in rejecting that request did not explain its reason for doing so. Shkreli's request that the Supreme Court take his appeal of federal court decision was his last chance to overturn the penalty related to the drug Daraprim . People pass outside the U.S. Supreme Court on October 7, 2024 in Washington, DC. Shkreli in June asked the Supreme Court to hear his appeal of that ruling, but only as it applied to the financial penalty. The attorney said that the Supreme Court should hear Shkreli's appeal to resolve the so-called circuit split on the question of a defendant's financial liability.
Persons: Martin Shkreli, Benjamin Brafman, Shkreli, pharma bro, Shkreli's Organizations: U.S, CNBC, Federal Trade Commission, pharma, Supreme, Vyera Pharmaceuticals, FTC, Circuit, Appeals Locations: Brooklyn, New York City, U.S, Washington ,, Manhattan, Shkreli, disgorgement
A federal judge temporarily barred notorious "pharma bro" Martin Shkreli from streaming or disseminating copies of a one-of-a-kind Wu-Tang Clan album he had forfeited as part of his criminal fraud conviction in 2017. Steven Cooper, a lawyer for PleasrDAO, said Wednesday that he could not comment on whether he has been in touch with prosecutors on Shkreli's alleged violation of his forfeiture order. Shkreli bought the Wu-Tang Clan album in 2015 for $2 million, setting a Guinness world record for the most expensive musical work ever sold. The 31-track, two-disc Wu-Tang Clan album, came in a hand-carved, nickel-and-silver-cased box set, which itself was nestled in a larger leather box. At the time of the sale, Shkreli owed almost $2.4 million on the forfeiture order.
Persons: Martin Shkreli, Benjamin Brafman, bro, Martin, Wu, Tang, Pamela Chen, Shkreli, Chen, Steven Cooper, PleasrDAO, Cooper, Lil Wayne, Carter, Pablo Picasso, Wu - Tang Organizations: U.S, CNBC, pharma, Wu - Locations: Brooklyn, New York City, U.S, Brooklyn , New York, Cayman Islands, Tasmania, Australia, United States
A federal appeals court Tuesday upheld a lifetime ban on "pharma bro" Martin Shkreli from working in the pharmaceuticals industry as well as an order to pay up to $64.6 million in disgorged profits for blocking competition to the drug Daraprim. His lawyer, Benjamin Brafman, in a statement to CNBC on the appeals court decision, said, "The lifetime ban is too severe." In its eight-page ruling, the appeals court noted that Shkreli argued that Manhattan federal court Judge Denise Cote "abused" her discretion in imposing a lifetime ban on him from the drug business. "The district court found, and Shkreli does not dispute, that Shkreli's illegal scheme was "egregious, deliberate, repetitive, long-running, and ultimately dangerous." "Given his strategic decision in the district court, there is no injustice to Shkreli by us declining to address his new argument."
Persons: Martin Shkreli, pharma bro, Shkreli, Benjamin Brafman, Brafman, Denise Cote, , Peluso Organizations: Turing Pharmaceuticals AG, pharma, U.S, Circuit, New, Federal Trade Commission, CNBC, FTC, Vyera Pharmaceuticals, Phoenixus, Mr Locations: New York, California, Manhattan
Martin Shkreli bragged that Sam Bankman-Fried asked him for advice on serving prison time. Shkreli did an interview with Tucker Carlson and said he told Bankman-Fried to "learn slang" and "invent a backstory." AdvertisementAdvertisementInfamous "Pharma Bro" Martin Shkreli, who was released from federal prison last year, bragged to Tucker Carlson that Sam Bankman-Fried asked him for advice on serving time in the slammer as the disgraced FTX founder faces the prospect of more than 100 years behind bars. That may be why Sam Bankman-Fried just asked his advice on doing time. AdvertisementAdvertisementAdditionally, Shkreli told Carlson that he believed Bankman-Fried would "most likely" go to prison for a "long time" and that he would be "screwed" behind bars.
Persons: Martin Shkreli, Sam Bankman, Fried, Shkreli, Tucker Carlson, Bankman, , Bro, Mark Botnick, He's, Hillary Clinton, vMGiqDk4tR — Tucker Carlson, there's, Carlson Organizations: Pharma, Service, Twitter, Fox News Locations: California, Oakland, Brooklyn
Martin Shkreli claims that under Elon Musk's leadership more than a dozen of his X accounts have been taken down. In total, he's tried to create up to 20 new accounts since his original was suspended in 2017, he told Fox Business. AdvertisementAdvertisementSo-called "Pharma Bro" Martin Shkreli claims that he's made himself more than a dozen accounts on the social-media platform X since Elon Musk took over, but that the site has subsequently taken them all down. "Elon preaches free speech, but his actions are showing the opposite," Shkreli told Fox Business. Shkreli told Fox Business that it was a "teasing war" and a "silly mistake."
Persons: Martin Shkreli, Elon, he's, Shkreli, Bro, Elon Musk, he'd, Musk, Daraprim, Letitia James, Kanye, Laura Loomer, Lauren Duca, Grimes Organizations: Fox Business, Morning, Elon, Twitter, Federal Trade Commission, New York, Facebook
Martin Shkreli is out of jail and earning $2,500 a month working as a consultant at a law firm. Shkreli is also living in Queens with his sister, per a report by the US Probation Office. A year after getting out of jail, Martin Shkreli — also known as "Pharma Bro" — is earning $2,500 as a consultant for a law firm, and living with his sister in Queens, New York. However, Shkreli was released from jail early in May 2022, after which he was transferred to a halfway house, where he lived until September. Upon getting out of jail, he posted a selfie of himself on Facebook, saying: "Getting out of real prison is easier than getting out of Twitter prison."
The ban also included a $64.6 million civil fine, which Shkreli said he is "so far unable" to pay. He said he intended to comply fully with the ban and provide requested information. The FTC had accused Shkreli last month of failing to provide information about Druglike Inc, a company it said he formed last July. He also said Druglike and DL Software were "software companies creating professional software for chemists and physicists," and thus outside his pharmaceutical industry ban. U.S. District Judge Denise Cote, who imposed the ban and $64.6 million penalty, will decide the FTC contempt motion.
[1/2] Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud, in the Brooklyn borough of New York City, U.S., August 4, 2017. REUTERS/Carlo AllegriWASHINGTON, Jan 20 (Reuters) - The U.S. Federal Trade Commission (FTC) asked a federal judge on Friday to hold Martin Shkreli in contempt for allegedly impeding its efforts to determine whether he flouted a ban on working in the pharmaceutical industry. Shkreli was released early from prison last May. U.S. District Judge Denise Cote imposed the lifetime drug industry ban and $64.6 million penalty last February, related to Shkreli's efforts to keep generic Daraprim rivals off the market. Reporting by Diane Bartz and Jon Stempel; Editing by Bill BerkrotOur Standards: The Thomson Reuters Trust Principles.
The Federal Trade Commission on Friday asked that notorious "pharma bro" Martin Shkreli be held in contempt of court for forming a new drug company in violation of a judge's ban on the convicted fraudster from working in the pharmaceuticals industry. In its court filing Friday, the FTC noted that Shkreli in July announced the formation of a new company, Druglike, "that appears to be involved in the drug industry." The FTC said Shkreli is required by Cote's order to provide the agency with that information. Benjamin Brafman, a lawyer for Shkreli, declined to comment on the FTC filing. Shkreli was driven back to New York from his prison in Pennsylvania by a friend, Edmund Sullivan, who had previously served on the board of Retrophin.
Total: 9